Thermo Fisher Scientific Inc (TMO), 2024 Q4 earnings digest

$TMO is set to release its Q4 earnings report, showcasing solid revenue growth of 5% year-over-year to $11.4 billion and adjusted EPS rising 8% to $6.10, reflecting strong operational performance. Key highlights include 23.9% adjusted operating margins and a positive trajectory across all business segments. Risks remain with continued fallout from COVID-related revenue runoff. As they look to 2025, they aim for revenue between $43.5 billion and $44 billion with EPS growth of 6% to 8%. Check details at http://valueverge.com/TMO.